1. Sanmarco, Liliana M, Rone, Joseph M, Polonio, Carolina M, Lora, Jose M, Quintana, Francisco J. 2023. Lactate limits CNS autoimmunity by stabilizing HIF-1α in dendritic cells. In Nature, 620, 881-889. doi:10.1038/s41586-023-06409-6. https://pubmed.ncbi.nlm.nih.gov/37558878/
2. Lin, Yuning, Xie, Hongyan, Zhao, Wenzhen, Li, Ying, Zhang, Zhongying. . NDUFA4L2 is a novel biomarker for colorectal cancer through bioinformatics analysis. In Medicine, 102, e35893. doi:10.1097/MD.0000000000035893. https://pubmed.ncbi.nlm.nih.gov/37933010/
3. Liu, Zhengye, Chaillou, Thomas, Santos Alves, Estela, Tavi, Pasi, Lanner, Johanna T. . Mitochondrial NDUFA4L2 is a novel regulator of skeletal muscle mass and force. In FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 35, e22010. doi:10.1096/fj.202100066R. https://pubmed.ncbi.nlm.nih.gov/34724256/
4. Chen, Zheng, Wei, Xiangyu, Wang, Xueyi, Li, Shiting, Zheng, Xuesheng. 2021. NDUFA4L2 promotes glioblastoma progression, is associated with poor survival, and can be effectively targeted by apatinib. In Cell death & disease, 12, 377. doi:10.1038/s41419-021-03646-3. https://pubmed.ncbi.nlm.nih.gov/33828084/
5. Zhou, Runlong, Sun, Zhe, Zhou, Ruijie, Wang, Zhenrong, Xu, Yao. 2024. Pancancer analysis of NDUFA4L2 with focused role in tumor progression and metastasis of colon adenocarcinoma. In Medical oncology (Northwood, London, England), 41, 285. doi:10.1007/s12032-024-02531-1. https://pubmed.ncbi.nlm.nih.gov/39402288/
6. Yuan, Yuan, Gao, Huanyao, Zhuang, Yongxian, Zhang, Lili, Wang, Liewei. 2021. NDUFA4L2 promotes trastuzumab resistance in HER2-positive breast cancer. In Therapeutic advances in medical oncology, 13, 17588359211027836. doi:10.1177/17588359211027836. https://pubmed.ncbi.nlm.nih.gov/34276814/
7. Tello, Daniel, Balsa, Eduardo, Acosta-Iborra, Bárbara, Cadenas, Susana, Landázuri, Manuel O. 2011. Induction of the mitochondrial NDUFA4L2 protein by HIF-1α decreases oxygen consumption by inhibiting Complex I activity. In Cell metabolism, 14, 768-79. doi:10.1016/j.cmet.2011.10.008. https://pubmed.ncbi.nlm.nih.gov/22100406/
8. Liu, Yun, Nie, Xiaowei, Zhu, Jinquan, Wang, Qian, Sun, Zengxian. 2020. NDUFA4L2 in smooth muscle promotes vascular remodeling in hypoxic pulmonary arterial hypertension. In Journal of cellular and molecular medicine, 25, 1221-1237. doi:10.1111/jcmm.16193. https://pubmed.ncbi.nlm.nih.gov/33340241/
9. Han, Peng, Zhang, Boxiang, Li, Yixing, Yang, Aimin, Liang, Yiqian. 2024. MiR-183-5p inhibits lung squamous cell carcinoma survival through disrupting hypoxia adaptation mediated by HIF-1α/NDUFA4L2 axis. In Oncogene, 43, 2821-2834. doi:10.1038/s41388-024-03129-7. https://pubmed.ncbi.nlm.nih.gov/39154121/
智鼠故事 
